# Porphyromonas gingivalis-derived lipopolysaccharide confers chemotherapy resistance and migratory ability on oral cancer cells by activating toll-like receptor 4 signaling pathway

**Authors:** Yoshiteru Yamashita, Hideo Shigeishi, Sho Yokoyama, Ryo Uetsuki, Fumie Shiba, Shigehiro Ono, Kouji Ohta, Tomonao Aikawa

PMC · DOI: 10.1007/s11033-026-11713-1 · 2026-03-27

## TL;DR

This study shows that a bacterial component from Porphyromonas gingivalis makes oral cancer cells more resistant to chemotherapy and more mobile by activating a specific signaling pathway.

## Contribution

The study reveals a novel mechanism by which P. gingivalis lipopolysaccharide promotes chemotherapy resistance and migration in oral cancer cells via TLR4/NF-κB signaling.

## Key findings

- P. g-LPS reduces 5-FU-induced cell death in oral cancer cells through TLR4/NF-κB activation.
- P. g-LPS enhances cell migration and promotes a more aggressive cancer cell phenotype.
- Blocking TLR4 or NF-κB signaling reverses the effects of P. g-LPS on chemotherapy resistance and migration.

## Abstract

This study examined the Porphyromonas gingivalis-derived lipopolysaccharide (P. g-LPS)-activated-toll-like receptor 4 (TLR4) pathway and its association with resistance to chemotherapy in oral squamous cell carcinoma (OSCC) cells.

The OSCC cell lines OM-1 and HOC621 were used in this study. Cells were treated with P. g-LPS, TAK-242 as a TLR4 inhibitor, SC75741 as a nuclear factor-kappa B (NF-κB) inhibitor, and AH-6809 as a prostaglandin E2 (PGE2) receptor antagonist. 5-Fluorouracil (5-FU)-induced cytotoxicity was investigated by measuring lactate dehydrogenase that leaked from damaged cells. 5-FU-induced cytotoxicity was attenuated by P. g-LPS in OM-1 cells and HOC621 cells, although this attenuation was relieved by TAK-242, TLR4 siRNA knockdown, or SC75741. P. g-LPS induced phosphorylation and nuclear translocation of NF-kB/p65, and enhanced cyclooxygenase 2 (COX2) expression and PGE2 production in OM-1 cells. 5-FU-induced cytotoxicity was enhanced by AH-6809 in P. g-LPS-treated OM-1 cells. Furthermore, P. g-LPS-promoted cell migration was inhibited by TAK-242 or SC75741 in OM-1 cells. This study also involved an additional experiment focusing on CD44high OSCC cells. 5-FU-induced cytotoxicity was attenuated by P. g-LPS in amoeboid CD44high OM-1 cells when cultured on laminin-332-coated silicone gel. Additionally, P. g-LPS enhanced cofilin-1 dephosphorylation and cell protrusion in amoeboid CD44high OM-1 cells.

P. g-LPS is involved in chemotherapy resistance of OM-1 cells by activating the TLR4/NF-kB pathway, which promotes the migratory ability of these cells, and enhancing PGE2 autocrine signaling. P. g-LPS plays a vital role in OSCC cells’ acquisition of a highly malignant phenotype.

The online version contains supplementary material available at 10.1007/s11033-026-11713-1.

## Linked entities

- **Genes:** TLR4 (toll like receptor 4) [NCBI Gene 7099], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513], CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960], cfl1.S (cofilin 1 (non-muscle) S homeolog) [NCBI Gene 379172]
- **Proteins:** ptges2.L (prostaglandin E synthase 2 L homeolog)
- **Chemicals:** 5-Fluorouracil (PubChem CID 3385)
- **Diseases:** oral squamous cell carcinoma (MONDO:0004958)
- **Species:** Porphyromonas gingivalis (taxon 837)

## Full-text entities

- **Genes:** CFL1 (cofilin 1) [NCBI Gene 1072] {aka CFL, HEL-S-15, cofilin}, SNAI2 (snail family transcriptional repressor 2) [NCBI Gene 6591] {aka SLUG, SLUGH, SLUGH1, SNAIL2, WS2D}, NANOG (Nanog homeobox) [NCBI Gene 79923], BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, CDH2 (cadherin 2) [NCBI Gene 1000] {aka ACOGS, ADHD8, ARVD14, CD325, CDHN, CDw325}, ALDH1A1 (aldehyde dehydrogenase 1 family member A1) [NCBI Gene 216] {aka ALDC, ALDH-E1, ALDH1, ALDH11, HEL-9, HEL-S-53e}, BMI1 (BMI1 proto-oncogene, polycomb ring finger) [NCBI Gene 648] {aka FLVI2/BMI1, PCGF4, RNF51, flvi-2/bmi-1}, PTGER1 (prostaglandin E receptor 1) [NCBI Gene 5731] {aka EP1}, SNAI1 (snail family transcriptional repressor 1) [NCBI Gene 6615] {aka SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, PTGER2 (prostaglandin E receptor 2) [NCBI Gene 5732] {aka COX-2, EP2}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, VIM (vimentin) [NCBI Gene 7431], POU5F1 (POU class 5 homeobox 1) [NCBI Gene 5460] {aka OCT3, OCT4, OCT4Borf1, OTF-3, OTF3, OTF4}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}
- **Diseases:** oral cancer (MESH:D009062), inflammation (MESH:D007249), OSCC (MESH:D000077195), non-small cell lung cancer (MESH:D002289), Periodontitis (MESH:D010518), breast cancer (MESH:D001943), Cytotoxicity (MESH:D064420), Tumor (MESH:D009369), chronic periodontitis (MESH:D055113), oral carcinogenesis (MESH:D063646), metastasis (MESH:D009362), chronic (MESH:D002908), OSCC cancer (MESH:D018307), glioma (MESH:D005910)
- **Chemicals:** glucose (MESH:D005947), SC75741 (MESH:C000720762), lipoteichoic acids (MESH:C009900), 5-FU (MESH:D005472), AH-6809 (MESH:C053876), P. (MESH:D010758), Alexa Fluor  488 (MESH:C000711379), CO2 (MESH:D002245), LPS (MESH:D008070), PGE2 (MESH:D015232), alcohol (MESH:D000438), 4',6-diamidino-2-phenylindole (MESH:C007293), Lipofectamine (MESH:C086724), penicillin (MESH:D010406), TAK-242 (MESH:C507035), Alexa Fluor 568 phalloidin (-), streptomycin (MESH:D013307), silicone (MESH:D012828), P. g (MESH:D011453)
- **Species:** Porphyromonas gingivalis (species) [taxon 837], Escherichia coli (E. coli, species) [taxon 562], Homo sapiens (human, species) [taxon 9606], Actinomyces (genus) [taxon 1654], herpesvirus [taxon 39059], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Mus musculus (house mouse, species) [taxon 10090], Fusobacterium (genus) [taxon 848], Human papillomavirus 16 (serotype) [taxon 333760]
- **Cell lines:** HOC621 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_8699), OM-1 — Homo sapiens (Human), Oral cavity squamous cell carcinoma, Cancer cell line (CVCL_W941)

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13031245/full.md

---
Source: https://tomesphere.com/paper/PMC13031245